BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 10 analysts with an average price target of $50.13. This is a potential upside of $25.12 (100.44%) from yesterday's end of day stock price of $25.01.

Beam Therapeutics 's activity chart (see below) currently has 105 price targets and 81 ratings on display. The stock rating distribution of BEAM is 28.57% HOLD and 71.43% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 66.87 days.

Highest price target for BEAM is $70, Lowest price target is $20, average price target is $40.13.

Most recent stock forecast was given by MICHAEL YEE from JEFFERIES on 08-Oct-2025. First documented stock forecast 01-Mar-2020.

Currently out of the existing stock ratings of BEAM, 6 are a HOLD (28.57%), 15 are a BUY (71.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$41

$13.04 (46.64%)

$30

23 days ago
(08-Oct-2025)

3/4 (75%)

$13.13 (47.11%)

177

Hold

$21

$-6.96 (-24.89%)

$25

2 months 26 days ago
(05-Aug-2025)

11/11 (100%)

$2.7 (14.75%)

145

Buy

$55

$27.04 (96.71%)

$78

5 months 25 days ago
(06-May-2025)

0/4 (0%)

$38.77 (238.88%)

Buy

$70

$42.04 (150.36%)

$105

5 months 25 days ago
(06-May-2025)

0/3 (0%)

$53.77 (331.30%)

$40

$12.04 (43.06%)

$57

6 months 9 days ago
(22-Apr-2025)

2/5 (40%)

$20.13 (101.31%)

4

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 66.87 days on average for the stock forecasts to be realized with a an average price target met ratio 32.86

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 7 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Mani Foroohar with highest potential upside - $49.04

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Luca Issi with lowest potential downside - -$7.96

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?